New Biology Fosters New Business Partnerships

November 6th, 2014
Posted by

You may have read the announcement this week of the joint venture between the preeminent medical genetics lab of Baylor College of Medicine and Japan-based Miraca, a holding company operating in the healthcare sector.

I am delighted to have had the opportunity to shape the strategy for this relationship and look forward to rolling up my sleeves and helping with the implementation.

Why do I think this is so exciting and interesting?

Through this venture, world-class academic science meets the commercialization capacity of a global multinational business organization.

This may become a great example of new business combinations that have the potential to take the evolving understanding of biology to a global stage, and to combine the best that academic innovation has to offer with the experience and resources exhibited by global businesses.

At Popper and Company, we talk a lot about public-private partnerships and we believe this model could work for many other organizations. I would love to hear from you about your ideas on this front. Please send me an email – and feel free to subscribe to our newsletter or follow us on Twitter to stay current on how this joint venture progresses and on a multitude of other life science business topics.

Like this content? Don’t miss an update.

About the Author:

I founded Popper and Company with Ken Walz more than ten years ago to address inefficiencies in health care by helping life science companies develop and commercialize new technology. Today, the members of our growing team leverage their extensive knowledge of the tools and trends shaping all aspects of health care and its participants. Send me an email.